Who’s afraid of the big bad boss? Plenty of us, new FSU study shows

The abusive boss has been well-documented in movies (“Nine to Five”), television (Fox’s “My Big Fat Obnoxious Boss”) and even the Internet. Now, a Florida State University professor and two of his doctoral students in Tallahassee, Fla. have conducted a study that shines some light on the magnitude of the problem and documents its effects on employee health and job performance.

Leukemia :: New hope for patients with chronic lymphocytic leukemia

Patients treated with lenalidomide for relapsed chronic lymphocytic leukemia or disease that no longer responds to chemotherapy have experienced a major response to therapy, according to a phase II study conducted by Asher Chanan-Khan, M.D., Department of Medicine, Roswell Park Cancer Institute. The results are published in the December 1 issue of the Journal of Clinical Oncology.

Psychiatry :: New direction for development of psychotropic drugs

A panel of academic, industry and government representatives, presenting at the ACNP Annual Meeting, concluded that several factors have impeded the development of novel treatments for mental illness, including: incomplete understanding of the impact of mental illness on the brain; continued skepticism of results from animal models for certain disorders, and an outdated paradigm of treatment and the industry preference toward so-called “me-too” drugs.

Skin Care :: Tea may help heal skin damaged by radiation

Skin damage caused by radiation treatment in cancer patients can be treated with tea extracts and researchers believe that this might be due to anti-inflammatory properties of tea which are extremely beneficial to damaged skin.

Schizophrenia :: Older Drug More Cost-Effective for Patients with Schizophrenia

A new study analyzing the economic implications of the Clinical Antipsychotic Trials of Intervention Effectiveness (CATIE) concludes that the older (first generation) antipsychotic medication perphenazine was less expensive and no less effective than the newer (second generation) medications used in the trial during initial treatment, suggesting that older antipsychotics still have a role in treating schizophrenia.

Stent :: FDA probes safety of popular heart stent

A Food and Drug Administration panel will meet on the issue to insure the safety of popular heart stent on Thursday and Friday. Medical journals are rushing studies into print, and powerful doctor groups are reconsidering treatment guidelines.

Dr. Anil Singhal Homeopathic Doctor | Dr. Anil Singhal's Blog | Manan - My Memoir by Dr. Anil Singhal | Boger's Legacy | Organon of Medicine | Health Newstrack